Voice Of China 中国之言

• The FDA warned physicians prescribing the acne medication to be aware of any signs of depression their patients might display.
• Accutane manufacturer Hoffman-LaRoche did not warn patients and healthcare professionals of the potential risks involved with Accutane until after the FDA made this advisement.

• In October 2001, Congressman Bart Stupak expressed his concerns about Accutane following the suicide of his son who happened to be taking Accutane.
• Accutane manufacturer has warned physicians that the acne drug can possibly cause "depression, psychotic symptoms, and rarely suicide attempts," but still the company maintains they believe the drug is safe.
• In addition, Accutane carries high risk of serious birth defects, including deformed babies, miscarriage, premature birth, or death of the baby.

• Instances of individuals and teenagers parents describing observations of serious feelings of depression while taking Accutane have continued to be made. In the U.S. congressional hearings on the controversy of Accutane have been surrounding the acne drug.
• The manufacturer believes that there is no evidence showing Accutane is responsible for feelings of depression or suicidal tendencies, but the death toll has continued to rise despite this.

• Since 1982, there have been 142 suicides involving Accutane.
• The FDA has required that doctors and patients sign a lengthy consent form prior to beginning Accutane therapy acknowledging they have been informed of the dangers.
• Other side effects of Accutane include brain problems, abdomen problems, bone and muscle problems, hearing problems, vision problems, lipids or fats and cholesterol in blood problems, and allergic reactions.

• Accutane is intended to treat the most severe form of acne that has been unresponsive to any other type of acne treatment.
• The FDA's implementation of the consent form was due to the claims of patients that they had suffered serious side effects and that they were unaware of the risks involved with the medication when beginning treatment.

source: www.adrugrecall.com

• Accolate is an asthma prescription medication.
• a nonsteroidal tablet intended for the prevention and continuous treatment of asthma in children and adults.
• Accolate is manufactured by Zeneca Pharmaceuticals.
• In approximately 10 months on the market, Accolate was prescribed to around 250,000 U.S. patients.

• On July 22, 1997, the manufacturer of Accolate sent a letter to healthcare professionals that the company was making changes to the enclosed package insert for the asthma drug.
• Included in the revisions were warnings that the drug had been associated to rare occurrences of eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy sometimes presenting as Churg Strauss Syndrome.
• The Precautions and Adverse Reactions sections of the revised package insert for Accolate included the changes.

• Accolate manufacturer AstraZeneca warned that Accolate side effects included severe liver damage.
• First surfacing in the beginning of 2000, Accolate side effects had been more closely monitored by the FDA.
• The FDA told AstraZeneca to alert physicians of the dangerous Accolate side effects in September 2000.
• The company did not send out official FDA warnings regarding Accolate side effects, but instead just sent out physician notices in that months Physicians Desk Reference.

• Women are at a much higher risk for suffering Accolate side effects like liver damage and it is advised for women to undergo regular blood tests to screen for the presence of Accolate side effects.
• Accolate patients experiencing fever, stomach pain, rash, jaundice, or nausea may be suffering serious Accolate side effects and should consult their physician immediately.

(source: http://www.adrugrecall.com)